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Introduction. Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi
Arabia. This study aimed to assess the eﬀectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for
endodontic treatment against Enterococcus faecalis. Calcium hydroxide Ca(OH)2 gold standard intracanal medicament was used for
comparison. Methods. The gas chromatography mass spectrometry (GC/MS) analysis was carried out to identify the components of
SPE. First, the consistency of SPE was accomplished according to ANSI/ADA speciﬁcation no 57. Forty-ﬁve single-rooted
mandibular premolars were infected with that of E. faecalis suspension. Colony-forming units (CFU) were counted before the
medicaments’ application (CFU-1) and after seven days of their applications (CFU-2). Group I: SPE, Group II: positive control
Ca(OH)2, and Group III: saline solution negative control. The microdilution method was applied to determine minimal inhibitory
concentration (MIC) and minimal bactericidal concentration (MBC) of SPE. Results. Thirty-two compounds were identiﬁed
(89.09%), with main components of benzyl isothiocyanate (BITC) (33.32%) and steroids (34%). CFU before and after using SPE and
Ca(OH)2 recorded a statistically signiﬁcant reduction in bacterial count (P � 0.006) and (P � 0.01), respectively. There was an
insigniﬁcant diﬀerence between CFU after using SPE and Ca(OH)2 (P � 0.210). On the contrary, comparing both medicaments with
the negative control saline group resulted in signiﬁcant diﬀerences, (P � 0.001) and (P � 0.007), respectively. Moreover, the equality
of minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of SPE is recorded. Conclusion. This
ﬁnding could be referred to the high content of bactericidal BITC in synergism with other antimicrobial components, representing
70.71% of SPE. Thus, SPE is a good candidate as an intracanal medicament, which warrants further investigation.

1. Introduction
The ultimate goal of an infected root canal preparation,
including cleaning, shaping, and using the disinfectant solution, is to entirely remove bacteria, their by-product, and
pulpal remnants. The microorganisms in the root canal of

the teeth are principally responsible for pulpal/periapical
diseases. The primary intraradicular infections have been
caused by many members of endodontic bacterial communities [1]. Some of them are persistent pathological
bacteria, including Streptococcus sanguinis, Streptococcus
mutans, Enterococcus faecalis, Fusobacterium nucleatum,
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Porphyromonas gingivalis, and Prevotella intermedia [2].
However, E. faecalis is signiﬁcantly more associated with
asymptomatic cases of primary endodontic infections.
Furthermore, E. faecalis is much more likely to be found in
cases of failed endodontic therapy [3]. The antibacterial
intracanal medication is used to eradicate bacteria in adults
and children’s root canal systems. Accordingly, the pain and
inﬂammation of pulpal and periapical tissues are reduced
[4, 5]. This represents an optimal root canal disinfection
protocol that guarantees a high success rate of root canal
treatment [6–8]. The most commonly used intracanal medicament is Ca(OH)2 because of its signiﬁcant bactericidal
eﬀect and inhibition of inﬂammatory exudates [8].
The foremost commonly utilized irrigants in endodontics are sodium hypochlorite (NaOCl), ethylenediamine-tetra-acetic acid (EDTA), and chlorhexidine
(CHX), which can cause destructive side eﬀects. Intracanal medicament such as Ca(OH)2 causes collagen
breakdown and leads to weakening of radicular dentin.
Numerous plants are utilized as phytomedicines in
dentistry since they have biological and antibacterial
impacts. In endodontics, plants and their extracts can be
utilized as irrigant and intracanal medicament to avoid
the potential side eﬀects caused by routine chemical
agents [9].
Salvadora persica L. (S. persica. Siwak) is a plant whose
roots, twigs, or stems have been used for many centuries as
oral hygiene tools, particularly in Saudi Arabia. Using Siwak
(tooth stick) for cleaning of mouth is advocated Islamic wellestablished beliefs [10].
Many studies have been demonstrated that extracts of
S. persica possess various antiplaque, antiperiopathic, anticaries, anti-inﬂammatory, and antimycotic eﬀects [11].
Extracts of S. persica as intracanal irrigant also proved
signiﬁcant antimicrobial activity on the oral pathogens in
both in vitro and in vivo [12–14]. The present in vitro study
was designed to assess the eﬀect of an experimental intracanal medicament based on SPE against the most causative
bacteria for endodontic pulpitis/periodontitis; E. faecalis.
The gold standard intracanal medicament Ca(OH)2 was
employed as positive control. The null hypothesis: there
would be no diﬀerence between Ca(OH)2, the gold standard
endodontic medicament, and SPE as an experimental
intracanal medicament in bactericidal activity against
E. faecalis for 7 days.

2. Materials and Methods
2.1. Materials. The materials used in this study were
S. persica sticks brought from Riyadh region in Saudi Arabia,
zinc oxide powder (zinc oxide; Prevest DenPro, Bari
Brahmana, India), and Ca(OH)2 endodontic medicament
(MetaPaste; META BIOMED, Chungcheongbuk-do, Republic of Korea).
The plant was identiﬁed by Dr. Talal Dahan, assistant
professor of plant classiﬁcation at Bisha University, Saudi
Arabia, and a voucher specimen (# 19750) was deposited in
properly labeled polythene bags for future reference at the
Herbarium Centre, College of Pharmacy, Umm Al-Qura
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University (UQU), Saudi Arabia. The authors followed
IUCN Policy Statement on Research Involving Species at
Risk of Extinction.
2.2. Preparation of SPE. The fresh plant sticks of S. persica
were freeze-dried and then ground to a ﬁne powder using a
commercially available food blender. The ground sample
(500 g) was used to prepare the extract. Consequently, petroleum ether extract was prepared by cold percolating 500 g
of dried powder of the plant sticks in one liter of petroleum
ether for 72 h, and every 24 h fresh solvent was used. The
solvent was removed and recovered in a rotary evaporator
(BÜCHI Rotavapor RII; Büchi Labortechnik, Flawil, Switzerland) at 40°C using a BÜCHI vacuum pump. At the last
stage, the oily extract was freeze-dried to ensure that solvents
were removed to yield 20 ml of an oily material (SPE) with a
powerful aromatic odor. SPE was kept in a brown screwcapped tube in a −20°C freezer until further analysis.
2.3. Gas Chromatography-Mass Spectrometry GC/MS
Analysis. Mass spectra were recorded using Shimadzu
GCMS-QP2010 (Kyoto, Japan) equipped with Rtx-5MS
fused bonded column (30 m × 0.25 mm internal diameter i.d
×0.25 µm ﬁlm thickness) (Restek, USA) and a split-splitless
injector. The initial column temperature was kept at 50°C for
3 min (isothermal), programmed to 300°C at a rate of 5°C/
min, and kept constant at 300°C for 10 min (isothermal).
Injector temperature was 280°C. Helium carrier gas ﬂow rate
was 1.37 ml/min. All the mass spectra were recorded applying the following conditions: (equipment current) ﬁlament emission current, 60 mA; ionization voltage, 70 eV;
and ion source, 220°C. Diluted samples (1% v/v) were injected with split mode (split ratio) 1 : 15.
2.3.1. Compounds Identiﬁcation. The identiﬁcation of
compounds was performed based on their retention indices
relative to a homologous series of n-alkanes (C8–C28) injected under the same conditions and matching their mass
spectra with National Institute of Standards and Technology
(NIST) (Gaithersburg, United States) and Wiley Library
database (John Wiley & Sons, Hoboken, New Jersey, United
States) as well as literature [15–19].
2.4. Collection of Extracted Teeth. A total sample size of 15
samples for each group was suﬃcient to reject the null
hypothesis that the bactericidal activity for Ca(OH)2 and
SPE was equal with probability (power) 0.8 as the true
probability of success among the intervention group is 0.65.
The Type I error probability associated with this test of this
null hypothesis was 0.05. The sample size was calculated by G
power program 3.1.9.2 (University of Düsseldorf,
Düsseldorf, Germany). Forty-ﬁve single root premolars
extracted teeth for periodontal or orthodontic reasons were
obtained from the department of oral surgery at a diﬀerent
governmental and private hospital in Makkah city, Saudi
Arabia. Teeth with previous endodontic therapy, fracture,
crack, resorption, and root caries were excluded from the
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study. The present study followed the ethical guidelines for
clinical investigation: ethical policy of the American Dental
Association (ADA) regarding the use of human subjects in
clinical research and approved by the Institutional Review
Board (IRB), 21 January 2019, Faculty of Dentistry, Umm
Al-Qura University, Saudi Arabia (IRB # 122-19).
2.5. Preparation of the Experimental Siwak-Based Extract
Endodontic Medicament
2.5.1. Determination of Consistency. The ﬁrst intended
procedure was to determine the appropriate powder/liquid
mixing ratio (zinc oxide powder/SPE) for the experimental
endodontic medicament. The purpose was to obtain a
smooth and homogeneous material whose consistency is
acceptable for clinical application. As well, the consistency
should be analogous to the control endodontic medicament, commercial Ca(OH)2 paste (MetaPaste). The consistency was accomplished according to ANSI/ADA
speciﬁcation no# 57 [20]. Using a sterile stainless spatula
and glass slab, the powder was added to the SPE in small
increments until the cement was of ideal consistency: that
is, until it formed a 2.5 cm string to connect the spatula to
the glass plate when the spatula is lifted from the mix (oneinch string method). The paste was creamy in consistency
but quite heavy. On obtaining the adequate consistency, the
constituents’ powder and liquid were quantiﬁed. It was
found that when one scoop provided with zinc oxide
powder mixed with one drop of SPE resulted in the required consistency [21].

2.5.2. Preparation of Extracted Tooth. All forty-ﬁve singlerooted premolars were decoronated to standardize their root
length. The working length was established to be 14-16 mm,
and the roots was undergone rotary standardized instrumentation up to X3-ProTaper Next (DENTSPLY Tulsa
Dental Specialties, Dentsply-Maillefer, Switzerland). An
irrigant 2.5% sodium hypochlorite NaOCl (HYPOSOL;
Prevest DenPro, Bari Brahmana, India) was used in each
instrument and ﬁnally dried with size 25 absorbent paper
points. Each root was placed in a closed test tube containing
3 ml of brain heart infusion (BHI) broth (BHI BROTH;
SPML—Saudi Prepared Media Laboratory, Riyadh, Saudi
Arabia) and sterilized by autoclaving at 121°C for 20 min and
then incubated for 24 h at 37°C to conﬁrm sterility by the
absence of turbidity.

2.5.3. Preparation of E. faecalis Suspension. E faecalis ATCC
29212 strain was grown on Bile Esculin agar media (BILE
AESCULIN AGAR; SPML—Saudi Prepared Media Laboratory, Riyadh, Saudi Arabia) at 37°C for 24 h. After growth,
bacterial suspension was prepared from grown bacterial
colonies by inoculation in brain heart infusion (BHI) broth
and adjusted to the optical density of approximately
1.5 × 108 CFU/ml by comparing its turbidity to a 0.5
McFarland standard spectrophotometrically.
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2.5.4. Infection of Root Canals. Two ml of sterile BHI broth
was removed from each root containing tube and replaced
by 2 ml of the prepared bacterial suspension. The tubes were
then closed and incubated at 37°C for 48 h.
2.5.5. Colony-Forming Unit-1 (CFU-1). After 48 h, predetermined contamination period of root canals was
elapsed, each root was removed from the tube under
complete aseptic precautions, and irrigated with sterile saline (100 µl). Later, a dry sterile absorbent paper of point size
25 was inserted into the root canal and left for 5 min. Afterwards, these paper points were transferred individually to
sterile test tubes, each containing 1 ml of sterile saline solution, vortexed for 30 seconds, and then four serial dilutions
were made for each tube. Aliquots of 10 µl of each dilution
were plated onto Bile Esculin (BE) agar plates and incubated
at 37°C for 24 h. The grown bacterial colonies were counted
and multiplied by their dilution factor to represent CFU-1/
ml.
2.5.6. Ex Vivo Testing of Antimicrobial Activity of the Experimental Medicaments. The 45 decoronated teeth were
randomly allocated into 3 equal groups (n � 15) by simple
random sampling using random digit table depending on
medicament used:
Group I: experimental Siwak extract-based
medicament
Group II: Ca(OH)2 paste (positive control)
Group III: sterile physiological saline as negative
control group
Medicaments were placed into root canals with lentulo
spiral (Dentsply-Maillefer, Swaziland) inserted to the full
working length. The root canal foramina were sealed by
sterile cotton pellets and the oriﬁces closed by temporary
restoration; then, the samples were kept in an incubator at
37°C for seven days.
2.5.7. Colony-Forming Unit-2 (CFU-2). Seven days later,
each root was irrigated with sterile normal saline, and then
the previous technique was repeated to obtain CFU-2.
2.5.8. The Minimal Inhibitory Concentration (MIC) and
Minimal Bactericidal Concentration (MBC) of SPE. The
MIC of the SPE was determined in 96 multiwell microtiter
plates using microdilution method [22] with minor modiﬁcations. SPE was adjusted to a concentration of 50 mg/ml in
cation-adjusted Mueller Hinton broth medium, then
pipetted 50 µl of cation-adjusted Mueller Hinton broth
medium into the ﬁrst well of the plate, and 50 µl of broth
medium was distributed from the 1st to the 12th well of each
row. Twofold serial dilution was achieved by transferring
50 µl of scalar dilution from the ﬁrst to the subsequent wells
of each row. The ﬁnal concentration of SPE adopted to
evaluate antibacterial activity was included from 25 mg/ml
to 0.003 mg/ml. Finally, 10 µL of E. faecalis suspension was
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added to each well. Two row lines in each plate were used as
controls: one row line with Ca(OH)2 as a positive control (in
a serial dilution of 25–0.003 mg/mL). Plates were incubated
at 37°C for 18–24 h. The lowest concentration at which no
turbidity occurred was taken as the MIC value. Plates were
analyzed individually to determine MIC, and the average
MIC values from three repeats were taken in determination
of the ﬁnal MIC values for each extract to ensure accuracy
and reproducibility. To determine the MBC of SPE, 50 μl of
the solution was removed from the well before the MIC well
and the well after the MIC well. The solution was inoculated
into tryptic soy agar plate and incubated at 37°C for 24 h.
2.6. Statistical Analysis. Data were collected, tabulated, and
statistically analyzed using Statistical Package for Social
Science (SPSS v.20, IBM. Released 2020. IBM SPSS Statistics
for Windows, Version 27.0. Armonk, NY: IBM). P < 0.05
was considered as a level of signiﬁcance. The mean and
standard deviation were tabulated and statistically analyzed
using one-way ANOVA test regarding the CFU-1 of the
three tested groups before using intracanal medication.
Regarding the CFU-2 of three groups, the mean and standard deviation were analyzed using one-way nonparametric
ANOVA (Kruskal–Wallis). Finally, the antimicrobial eﬀect
of diﬀerent tested medications on E. faecalis was tabulated
and statistically analyzed using paired t-test.

3. Results
3.1. Chemical Composition of SPE. Analysis of SPE by GC
and GC/MS revealed that SPE contained 32 compounds, of
which benzyl isothiocyanate (33.32%), c-sitosterol (25.76%),
stigmasterol (5.92%), β-sitosterol acetate (2.28%), n-hexadecanoic acid (4.27%), and (Z)-11-octadecenoic acid
(3.16%) were found to be the major constituents. Compounds are listed in order of their elution times on Rtx-5MS
column in Table 1.
3.2. SPE Endodontic Therapy. The statistical analysis of the
CFU-1 of three tested groups before using intracanal
medications (SPE and Ca(OH)2) was tabulated in Table 2. It
was evident that there were no signiﬁcant diﬀerences in
bacterial counts among them (P � 0.359). Table 2 shows the
statistical analysis using paired t-test of the number of the
CFU of E. faecalis before and after applying the investigated
medicaments at the root canal lumens; CFU-1 and CFU-2,
respectively. The results showed a signiﬁcant diﬀerence
between CFU-1 and CFU-2 either in using SPE (P � 0.006)
or Ca(OH)2 (P � 0.011). On the other hand, the bacterial
count of the negative control group showed a nonsigniﬁcant
diﬀerence between CFU-1 and CFU-2 (P � 0.438). Finally,
the bacterial count’s signiﬁcant diﬀerence among the three
tested groups was compared using one-way nonparametric
ANOVA. The values were insigniﬁcantly diﬀerent between
bacterial counts after using SPE and Ca(OH)2 (P � 0.210).
On the contrary, comparing both medicaments with the
negative control saline group resulted in signiﬁcant diﬀerences (P � 0.001) and (P � 0.007), respectively.
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3.3. MIC and MBC of SPE. The MIC of SPE and Ca(OH)2
were measured to be 3.5 and 4.2 mg/ml, respectively. No
growth in the MIC well and the well before that and bacterial
growth in the well after the MIC well indicated equality of
MBC and MIC of SPE.

4. Discussion
The chemomechanical cleaning and shaping of the root
canals of the teeth are essential for the success of endodontic
therapy [23, 24]. Yet, intracanal medication is a crucial
procedure during root canal treatment where the probability
of complete eradication of bacteria is questionable [25].
It is well documented that the use of biocompatible
intracanal medications possessing antimicrobial properties
between appointments destroys and eradicates bacteria in
the root canal system [26]. It was proven that E. faecalis is the
most predominant bacteria found in the infected root canal
[27]. Unfortunately, this species has the ability to survive in
hard environment with deprived nutrients and alkaline pH
reaching up to 11.5 that implies a challenge to be completely
exterminated from root canal system [28, 29].
Calcium hydroxide Ca(OH)2 is the gold standard
intracanal medication used in the treatment of infected root
canals, referring to its well-known antibacterial features and
ease of application [30, 31]. The eﬀect of both SPE and
Ca(OH)2 against E. faecalis was considered in the presence
of a negative control group saline, to specify the antimicrobial eﬀect. The antimicrobial eﬀect of the experimental
medicament SPE insigniﬁcantly surpasses that of Ca(OH)2
(P � 0.210), as shown in Table 2. In the present investigation, SPE experimental intracanal medicament (Group l)
proved an eﬀective eradication of E. faecalis. This ﬁnding was
in agreement with the results reported about the usefulness
of SPE as endodontic irrigant against E. faecalis [32]. As well,
it was evidenced that S. persica has an inhibitory eﬀect on the
growth of the oral pathogen [33]. The MIC value of SPE was
in agreement with those reported for aqueous and methanol
extracts of S. persica against E. faecalis [34] and for Ca(OH)2
[35]. MIC of SPE is recorded in the current study for the ﬁrst
time.
In this study, the chemical proﬁle representing 32
compounds of SPE was identiﬁed by GC/MS (89.09%) and
listed in Table 1. The major component was found to be
benzyl isothiocyanate. This compound was reported as the
most robust antibacterial component with high bactericidal
activity against Gram-negative periodontal pathogens [36].
The potent antibacterial eﬀect of the experimental medicament, as shown in Table 2, suggested that SPE targeted the
bacterial membrane, whereas BITC has both lipophilic and
electrophilic properties. It is reported that BITC penetrates
through the outer bacterial membrane and possibly interfered with the bacterial redox systems, thus hampering the
bacterium’s ability to maintain its membrane potential. Such
an eﬀect of BITC has been demonstrated for mitochondrial
membranes [37].
In addition, there are c-sitosterol (25.76%), n-hexadecanoic acid (4.27%), and (Z)-11-octadecenoic acid
(3.16%) that are reported as potent broad-spectrum
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Table 1: The chemical proﬁle of SPE.
Rt

Component

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

18.35
20.47
21.14
23.76
26.24
34.40
34.91
36.12
37.86
37.92

11.

38.15

12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.

38.24
38.36
42.84
48.95
49.51
51.09
51.69
51.87
52.06
52.17
52.47
52.66
52.94
53.28
54.89
55.40
56.44
57.47
58.21
59.04
60.19

Carvacrol
Benzyl isothiocyanate
n-Tetradecane
n-Pentadecane
n-Hexadecane
n-Hexadecanoic acid (palmitic acid)
Hexadecanoic acid ethyl ester
Cyclic octaatomic sulphur
Oleic acid
(Z)-11-Octadecenoic acid
(Z,Z)-9,12-Octadecadienoyl chloride (linoleic acid
chloride)
(Z)-9-Octadecenoic acid ethyl ester (oleic acid ethyl ester)
9-Octadecenoic acid ethyl ester
p-Cresol, 2,2′-methylene bis [6-tert-butylSqualene
N-Benzylpalmitamide
Stigmasta-3,5-diene
Stigmasterol acetate
3β-Acetoxystigmasta-4,6,22-triene
n-Benzyloctadecenamide (n-benzyloleamide)
Stigmasta-5,22-dien-3-ol, acetate
Clionasterol acetate
Stigmastan-3,5,22-triene
β-Sitosterol acetate
Cholesterol
Campesterol
Stigmasterol
c-Sitosterol
Unidentiﬁed
3,5-Stigmastadien-7-one
Sitostenone
Lupeol
% total identiﬁed

Peak #

Molecular
formula
C10H14O
C8H7NS
C14H30
C15H32
C16H34
C16H32O2
C18H36O2
S8
C18H34O2
C18H34O2

RIexpa RIlitb Content (%) Identiﬁcationc
1288
1359
1400
1500
1600
1946
1975
2055
2130
2117

0.57
33.32
0.21
0.38
0.13
4.27
0.13
0.99
1.95
3.16

MS,
MS,
MS,
MS,
MS,
MS,
MS,
MS,
MS,
MS,

C18H31ClO

2146 2139

0.37

MS, KI

C20H38O2
C20H38O2
C23H32O2
C30H50
C23H39NO
C29H48
C31H50O2
C31H48O2
C25H41NO
C31H50O2
C31H52O2
C29H46
C31H52O2
C27H46O
C28H48O
C29H48O
C29H50O
C29H46O
C29H48O
C30H50O

2151
2157
2403
2796
2832
2934
2972
2984
2996
3003
3022
3034
3052
3074
3177
3210
3277
3344
3391
3444
3518

0.45
0.14
0.13
0.17
0.36
0.77
0.12
0.24
0.53
0.65
0.50
1.89
2.28
0.66
0.70
5.92
25.76
3.57
0.56
0.54
1.24
89.09

MS, KI
MS, KI
MS, KI
MS, KI
MS
MS
MS, KI
MS
MS, KI
MS
MS
MS, KI
MS
MS, KI
MS
MS, KI
MS, KI
MS
MS, KI
MS

1288
1361
1384
1485
1582
1948
1972
2034
2130
2133

2168
2171
2398
2814
2880
—
2879
2991
2981
3075
3131
3213
3290
3435
3451

KI
KI
KI
KI
KI
KI
KI
KI
KI
KI

Compounds are listed in order of their elution times on Rtx-5MS column. aRIexp, retention index determined experimentally relative to C8 – C28 n-alkanes on
Rtx-5MS column; bRIlit, published retention indices; cIdentiﬁcation, was based on comparison of the compounds’ mass spectral data (MS) and retention
indices (RI) with those of NIST Mass Spectral Library (2017), Wiley Registry of Mass Spectral Data 8th edition and literature. Bold shows major components.

Table 2: The descriptive statistical analysis of the E. faecalis count before (CFU-1) and after (CFU-2) the application of the medicaments.
Bacterial count groups
Group I Siwak
Group II Ca(OH)2 (+ve control)
Group III Saline (−ve control)

antimicrobials [38–42]. Moreover, SPE has antimicrobial
eﬀect against both Gram-positive and Gram-negative bacteria due to the presence of carvacrol (0.57%) conﬁrmed by
Memar et al. (2017) [43]. SPE components in Table 1 show
the presence of n-tetradecane (0.21%), n-hexadecane
(0.13%), 11-octadecenoic acid (3.16%), squalene (0.17%),
stigmasterol (0.12%), sitosterol (2.28%), and sitostenone
(0.54%), and these components are potent antibacterial
agents [44–48]. Therefore, SPE’s strong bactericidal eﬀect is
attributed to the antimicrobial components that represents a
percentage of 70.71% of the extract. It is worthy to mention
that some components with anti-inﬂammatory and

CFU-1
Mean ± SD
48.9 ± 53.7 ∗ 104
51.6 ± 68.4 ∗ 104
56.3 ± 59 ∗ 104

CFU-2
Mean ± SD
0.0250 ± 0.1 ∗ 104
0.07 ± 0.25 ∗ 104
50 ± 115 ∗ 104

antioxidant eﬀects are identiﬁed as oleic acid (1.95%), 11octadecenoic acid (3.16%), 2,2′-methylenebis (6-tert-butyl4-methylphenol) (0.13%), squalene (0.17%), n-benzyloleamide (0.53%), n-benzylpalmitamide (0.36%) stigmasta-5,
22-dien-3-ol (0.65%) lupeol (1.24%), and hexadecanoic acid,
ethyl ester (0.13%) [46, 47, 49].
Based on the obtained results, the null hypothesis is
accepted as the experimental intracanal medicament SPE, a
novel trial in the ﬁeld of endodontic treatment, has nonsigniﬁcant diﬀerence in antimicrobial activity comparing to
the gold standard; Ca(OH)2 against E. faecalis. However,
further studies are suggested to explicate SPE eﬀect against
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other reported endodontic pathogens. Moreover, the limitations of this study as the assessment of the activity against
the bioﬁlm formation that resembles the clinical situation
should be investigated after the evaluation of the eﬀect of
SPE in an in vivo study. SPE comprises potent antimicrobial
and anti-inﬂammatory components as identiﬁed by GC/MS.
Thus, it could be claimed that it will be a robust intracanal
medicament. However, its anti-inﬂammatory eﬀect is still
under investigation by the authors.

5. Conclusion
Within the limitations of this Ex vivo study, SPE can eﬃciently eradicate E. faecalis from the root canal system by
many antimicrobial components. It could be used as a good
alternative to calcium hydroxide in endodontic therapy;
however, further studies are recommended to investigate its
eﬃcacy in an in vivo assessment and inhibitory eﬀects on
bioﬁlm formation before engaging it in regular dental
practice.
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Supplementary Materials
S1: Salvadora persica plants’ sticks. S2: Salvadora persica petether extract. S3: prepared 45 extracted teeth. S4: prepared 45
extracted teeth in BHI tubes and prepared for incubation at
37°C for 48 hours. Two ml of sterile BHI broth was removed
from each root-containing tube and replaced by 2 ml of the
prepared bacterial suspension. The tubes were then closed
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and incubated at 37°C for 48 h. S5: bile esculin (BE) agar
showing a high number of growing colonies of E. faecalis
before application of medicaments. S6: BE agar showing no
growing colonies of E. faecalis after application of Siwak as a
medicament (CFU2). S7: BE agar showing a few number of
growing colonies of E. faecalis after application of Ca(OH)2
(CFU2). S8: BE agar showing a high number of growing
colonies of E. faecalis after using saline (CFU2). S9: GC/MS
total ion chromatogram (TIC) of Salvadora sp. petroleum
ether extract. GCMS revealed the identiﬁcation of 32
compounds from SPE by comparing their mass spectra with
the National Institute of Standards and Technology (NIST)
(Gaithersburg, United States) and Wiley library database
(John Wiley & Sons, Hoboken, New Jersey, United States), as
well as the literature. (Supplementary Materials)
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